Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers

NANot yet recruitingINTERVENTIONAL

Enrollment

189

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

January 2, 2026

Study Completion Date

September 2, 2026

Conditions

Alzheimer Blood Biomarkers

Interventions

DIAGNOSTIC_TEST

Blood ponction

Trial Locations (1)

CHRU De Nancy, Nancy

All Listed Sponsors

collaborator

Thérèse Jonveaux

UNKNOWN

collaborator

Laure Joly

UNKNOWN

collaborator

Lucie Hopes

UNKNOWN

collaborator

Maia Simon

UNKNOWN

collaborator

Franck Schreiner

UNKNOWN

lead

Central Hospital, Nancy, France

OTHER

NCT06304129 - Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers | Biotech Hunter | Biotech Hunter